Pharmaceuticals in South Africa

Pharmaceuticals in South Africa


Summary

Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2018-23, and forecast to 2028). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values refer to the value generated by market players.
  • The South African pharmaceuticals market registered revenues of $4.9 billion in 2023, representing a compound annual growth rate (CAGR) of 7.5% between 2018 and 2023.
  • The South African pharmaceuticals market witnessed a decelerated growth in 2023, registering an annual growth of 1.9% from 4.3% in 2022.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in South Africa
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Africa
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the South Africa pharmaceuticals market with five year forecasts
Reasons to Buy
  • What was the size of the South Africa pharmaceuticals market by value in 2023?
  • What will be the size of the South Africa pharmaceuticals market in 2028?
  • What factors are affecting the strength of competition in the South Africa pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in South Africa's pharmaceuticals market?


1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market rivalry
1.5. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths of leading players?
7.3. What are the recent developments in the market?
8 Company Profiles
8.1. Aspen Pharmacare Holdings Ltd
8.2. Adcock Ingram Holdings Ltd
8.3. Bayer AG
8.4. Pfizer Laboratories (Pty) Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: South Africa pharmaceuticals market value: $ billion, 2018-23
Table 2: South Africa pharmaceuticals market geography segmentation: $ billion, 2023
Table 3: South Africa pharmaceuticals market value forecast: $ billion, 2023-28
Table 4: Aspen Pharmacare Holdings Ltd: Key Facts
Table 5: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
Table 6: Aspen Pharmacare Holdings Ltd: Key Employees
Table 7: Adcock Ingram Holdings Ltd: Key Facts
Table 8: Adcock Ingram Holdings Ltd: Annual Financial Ratios
Table 9: Adcock Ingram Holdings Ltd: Key Employees
Table 10: Bayer AG: Key Facts
Table 11: Bayer AG: Annual Financial Ratios
Table 12: Bayer AG: Key Employees
Table 13: Bayer AG: Key Employees Continued
Table 14: Pfizer Laboratories (Pty) Ltd: Key Facts
Table 15: Pfizer Laboratories (Pty) Ltd: Key Employees
Table 16: South Africa Size of Population (million), 2019-23
Table 17: South Africa Real GDP (constant 2010 prices, $ billion), 2019-23
Table 18: South Africa GDP (current prices, $ billion), 2019-23
Table 19: South Africa Inflation, 2019-23
Table 20: South Africa Consumer Price Index (absolute), 2019-23
Table 21: South Africa Exchange Rate, 2018-23
List of Figures
Figure 1: 220 Laboratories Inc: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
Figure 2: 220 Laboratories Inc: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
Figure 3: 220 Laboratories Inc: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings